Igor Feldman PhD

Igor Feldman is a Co-Founder and has served as the Head of Computational Biology at Verseau since January 2017. Igor has held positions at Merck & Co., Rosetta Informatics, Jounce Therapeutics, and Epizyme. He has been involved in the discovery and clinical development using large omics datasets of human tumors, drug response biomarker discovery, novel target discovery in immuno-oncology and epigenetics and establishing computational infrastructure from the ground up for early discovery and development support in several biotech startup companies. He is an inventor on eight U.S. patents. Igor holds a B.S. in biology and a Ph.D. in systems biology from Columbia University.